Resveratrol and lifespan in model organisms

Current Medicinal Chemistry

Volumn 23, Issue 41, 2016, Pages 4639-4680

  Pallauf, Kathrin ^a   Rimbach, Gerald ^a   Rupp, Petra Maria ^a   Chin, Dawn ^a   Wolf, Insa M A ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Caloric restriction mimetic; Energy restriction; Longevity; Polyphenol; Red wine; Stilbene

Indexed keywords

RESVERATROL; STILBENE DERIVATIVE;

AGING; DIET; GENDER; GENE EXPRESSION; GENETIC BACKGROUND; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; NONHUMAN; OBESITY; REVIEW; ANIMAL; CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; LONGEVITY;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; LONGEVITY; STILBENES;

EID: 85009128688     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666161024151233     Document Type: Review

References (350)

1. Bhullar, K. S.; Hubbard, B. P. Lifespan and healthspan extension by resveratrol. Biochim. Biophys. Acta, 2015, 1852(6), 1209-1218.
2. Frankel, E. N.; Kanner, J.; German, J. B.; Parks, E.; Kinsella, J. E. Inhibition of oxidation of human low-density lipopro-tein by phenolic substances in red wine. Lancet, 1993, 341(8843), 454-457.
3. Colman, R. J.; Anderson, R. M.; Johnson, S. C.; Kastman, E. K.; Kosmatka, K. J.; Beasley, T. M.; Allison, D. B.; Cruzen, C.; Simmons, H. A.; Kemnitz, J. W.; Weindruch, R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science, 2009, 325(5937), 201-204.
4. Jiang, J. C.; Jaruga, E.; Repnevskaya, M. V.; Jazwinski, S. M. An intervention resembling caloric restriction prolongs life span and retards aging in yeast. FASEB J., 2000, 14(14), 2135-2137.
5. Kealy, R. D.; Lawler, D. F.; Ballam, J. M.; Mantz, S. L.; Biery, D. N.; Greeley, E. H.; Lust, G.; Segre, M.; Smith, G. K.; Stowe, H. D. Effects of diet restriction on life span and age-related changes in dogs. J. Am. Vet. Med. Assoc., 2002, 220(9), 1315-1320.
6. Weindruch, R.; Walford, R. L.; Fligiel, S.; Guthrie, D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr., 1986, 116(4), 641-654.
7. Liao, C. Y.; Rikke, B. A.; Johnson, T. E.; Diaz, V.; Nelson, J. F. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell, 2010, 9(1), 92-95.
8. Swindell, W. R. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res. Rev., 2012, 11(2), 254-270.
9. Lee, C-K.; Allison, D. B.; Brand, J.; Weindruch, R.; Prolla, T. A. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc. Natl. Acad. Sci. USA, 2002, 99(23), 14988-14993.
10. Mattison, J. A.; Roth, G. S.; Beasley, T. M.; Tilmont, E. M.; Handy, A. M.; Herbert, R. L.; Longo, D. L.; Allison, D. B.; Young, J. E.; Bryant, M.; Barnard, D.; Ward, W. F.; Qi, W.; Ingram, D. K.; de Cabo, R. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature, 2012, 489(7415), 318-321.
11. Lefevre, M.; Redman, L. M.; Heilbronn, L. K.; Smith, J. V.; Martin, C. K.; Rood, J. C.; Greenway, F. L.; Williamson, D. A.; Smith, S. R.; Ravussin, E.; Pennington, C. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis, 2009, 203(1), 206-213.
12. Meyer, T. E.; Kovács, S. J.; Ehsani, A. A.; Klein, S.; Hollo-szy, J. O.; Fontana, L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol., 2006, 47(2), 398-402.
13. Melov, S. Geroscience approaches to increase healthspan and slow aging. F1000 Res., 2016, 5, pii: F1000.
14. Ingram, D. K.; Zhu, M.; Mamczarz, J.; Zou, S.; Lane, M. A.; Roth, G. S.; deCabo, R. Calorie restriction mimetics: an emerging research field. Aging Cell, 2006, 5(2), 97-108.
15. Roth, G. S.; Ingram, D. K.; Lane, M. A. Caloric restriction in primates and relevance to humans. Ann. N. Y. Acad. Sci., 2001, 928, 305-315.
16. Ingram, D. K.; Anson, R. M.; de Cabo, R.; Mamczarz, J.; Zhu, M.; Mattison, J.; Lane, M. A.; Roth, G. S. Development of calorie restriction mimetics as a prolongevity strategy. Ann. N. Y. Acad. Sci., 2004, 1019, 412-423.
17. Soleas, G. J.; Diamandis, E. P.; Goldberg, D. M. Resveratrol: a molecule whose time has come? And gone? Clin. Bio-chem., 1997, 30(2), 91-113.
18. Trela, B. C.; Waterhouse, A. L. Resveratrol: Isomeric Molar Absorptivities and Stability. J. Agric. Food Chem., 1996, 44(5), 1253-1257.
19. Douillet-Breuil, A. C.; Jeandet, P.; Adrian, M.; Bessis, R. Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. J. Agric. Food Chem., 1999, 47(10), 4456-4461.
20. Langcake, P.; Pryce, R. J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol., 1976, 9(1), 77-86.
21. Sato, M.; Suzuki, Y.; Okuda, T.; Yokotsuka, K. Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci. Biotechnol. Biochem., 1997, 61(11), 1800-1805.
22. Ferrigni, N. R.; McLaughlin, J. L.; Powell, R. G.; Smith, C. R., Jr. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J. Nat. Prod., 1984, 47(2), 347-352.
23. Moreno-Labanda, J. F.; Mallavia, R.; Pérez-Fons, L.; Li-zama, V.; Saura, D.; Micol, V. Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vi-tis vinifera L.) grape variety. J. Agric. Food Chem., 2004, 52(17), 5396-5403.
24. Langcake, P.; Cornford, C. A.; Pryce, R. J. Identification of pterostilbene as a phytoalexin from Vitis vinifera leaves. Phytochemistry, 1979, 18(6), 1025-1027.
25. Langcake, P.; Pryce, R. J. Oxidative dimerisation of 4-hydroxystilbenes in vitro: production of a grapevine phytoa-lexin mimic. J. Chem. Soc. Chem. Commun., 1977, (7), 208.
26. Langcake, P.; Pryce, R. J. A new class of phytoalexins from grapevines. Experientia, 1977, 33(2), 151-152.
27. Pezet, R.; Perret, C.; Jean-Denis, J. B.; Tabacchi, R.; Gindro, K.; Viret, O. Delta-viniferin, a resveratrol dehydro-dimer: one of the major stilbenes synthesized by stressed grapevine leaves. J. Agric. Food Chem., 2003, 51(18), 5488-5492.
28. Takaya, Y.; Yan, K. X.; Terashima, K.; Ito, J.; Niwa, M. Chemical determination of the absolute structures of resveratrol dimers, ampelopsins A, B, D and F. Tetrahedron, 2002, 58(36), 7259-7265.
29. Seya, K.; Kanemaru, K.; Sugimoto, C.; Suzuki, M.; Takeo, T.; Motomura, S.; Kitahara, H.; Niwa, M.; Oshima, Y.; Fu-rukawa, K. Opposite effects of two resveratrol (trans-3, 5, 4-trihydroxystilbene) tetramers, vitisin A and hopeaphenol, on apoptosis of myocytes isolated from adult rat heart. J. Pharmacol. Exp. Ther., 2009, 328(1), 90-98.
30. Tanaka, T.; Ito, T.; Nakaya, K.; Iinuma, M.; Riswan, S. Oligostilbenoids in stem bark of Vatica rassak. Phytochem-istry, 2000, 54(1), 63-69.
31. Tanaka, T.; Ito, T.; Nakaya, K-i.; Iinuma, M.; Takahashi, Y.; Naganawa, H.; Matsuura, N.; Ubukata, M. Vaticanol D, a novel resveratrol hexamer isolated from Vatica rassak. Tetrahedron Lett., 2000, 41(41), 7929-7932.
32. Yang, H.; Baur, J. A.; Chen, A.; Miller, C.; Adams, J. K.; Kisielewski, A.; Howitz, K. T.; Zipkin, R. E.; Sinclair, D. A. Design and synthesis of compounds that extend yeast repli-cative lifespan. Aging Cell, 2007, 6(1), 35-43.
33. Nakata, R.; Takahashi, S.; Inoue, H. Recent advances in the study on resveratrol. Biol. Pharm. Bull., 2012, 35(3), 273-279.
34. Burns, J.; Yokota, T.; Ashihara, H.; Lean, M. E.; Crozier, A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem., 2002, 50(11), 3337-3340.
35. Adrian, M.; Jeandet, P. Effects of resveratrol on the ultra-structure of Botrytis cinerea conidia and biological significance in plant/pathogen interactions. Fitoterapia, 2012, 83(8), 1345-1350.
36. Fornara, V.; Onelli, E.; Sparvoli, F.; Rossoni, M.; Aina, R.; Marino, G.; Citterio, S. Localization of stilbene synthase in Vitis vinifera L. during berry development. Protoplasma, 2008, 233(1-2), 83-93.
37. Counet, C.; Callemien, D.; Collin, S. Chocolate and cocoa: New sources of trans-resveratrol and trans-piceid. Food Chem., 2006, 98(4), 649-657.
38. Tokusoglu, O.; Unal, M. K.; Yemis, F. Determination of the phytoalexin resveratrol (3, 5, 4-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J. Agric. Food Chem., 2005, 53(12), 5003-5009.
39. Zamora-Ros, R.; Andres-Lacueva, C.; Lamuela-Raventós, R. M.; Berenguer, T.; Jakszyn, P.; Martínez, C.; Sánchez, M. J.; Navarro, C.; Chirlaque, M. D.; Tormo, M-J.; Quirós, J. R.; Amiano, P.; Dorronsoro, M.; Larrañaga, N.; Barri-carte, A.; Ardanaz, E.; González, C. A. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br. J. Nutr., 2008, 100(1), 188-196.
40. Williams, L. D.; Burdock, G. A.; Edwards, J. A.; Beck, M.; Bausch, J. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem. Toxicol., 2009, 47(9), 2170-2182.
41. Lyons, M. M.; Yu, C.; Toma, R. B.; Cho, S. Y.; Reiboldt, W.; Lee, J.; van Breemen, R. B. Resveratrol in raw and baked blueberries and bilberries. J. Agric. Food Chem., 2003, 51(20), 5867-5870.
42. Romero-Pérez, A. I.; Ibern-Gómez, M.; Lamuela-Raventós, R. M.; de La Torre-Boronat, M. C. Piceid, the major resvera-trol derivative in grape juices. J. Agric. Food Chem., 1999, 47(4), 1533-1536.
43. Lamuela-Raventos, R. M.; Waterhouse, A. L. Occurrence of resveratrol in selected California wines by a new HPLC method. J. Agric. Food Chem., 1993, 41(4), 521-523.
44. Feijóo, O.; Moreno, A.; Falqué, E. Content of trans- and cis-resveratrol in Galician white and red wines. J. Food Compos. Anal., 2008, 21(8), 608-613.
45. Romero-Pérez, A. I.; Lamuela-Raventós, R. M.; Waterhouse, A. L.; de la Torre-Boronat, M. C. Levels of cis- and trans-Resveratrol and Their Glucosides in White and Rosé Vitis vinifera Wines from Spain. J. Agric. Food Chem., 1996, 44(8), 2124-2128.
46. Moreno, A.; Castro, M.; Falqué, E. Evolution of trans- and cis-resveratrol content in red grapes (Vitis vinifera L. cv Mencía, Albarello and Merenzao) during ripening. Eur. Food Res. Technol., 2008, 227(3), 667-674.
47. Stervbo, U.; Vang, O.; Bonnesen, C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem., 2007, 101(2), 449-457.
48. Martínez-Ortega, M. V.; Carcía-Parrilla, M. C.; Troncoso, A. M. Resveratrol content in wines and musts from the south of Spain. Nahrung, 2000, 44(4), 253-256.
49. Jeandet, P.; Bessis, R.; Maume, B. F.; Meunier, P.; Peyron, D.; Trollat, P. Effect of Enological Practices on the Resveratrol Isomer Content of Wine. J. Agric. Food Chem., 1995, 43(2), 316-319.
50. Mattivi, F.; Reniero, F.; Korhammer, S. Isolation, Characterization, and Evolution in Red Wine Vinification of Resveratrol Monomers. J. Agric. Food Chem., 1995, 43(7), 1820-1823.
51. Gambuti, A.; Strollo, D.; Ugliano, M.; Lecce, L.; Moio, L. trans-Resveratrol, quercetin, (+)-catechin, and (-)-epicatechin content in south Italian monovarietal wines: relationship with maceration time and marc pressing during winemaking. J. Agric. Food Chem., 2004, 52(18), 5747-5751.
52. Romero-Pérez, A. I.; Lamuela-Raventós, R. M.; Andrés-Lacueva, C.; de La Torre-Boronat, M. C. Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content. J. Agric. Food Chem., 2001, 49(1), 210-215.
53. Hurst, W. J.; Glinski, J. A.; Miller, K. B.; Apgar, J.; Davey, M. H.; Stuart, D. A. Survey of the trans-resveratrol and transpiceid content of cocoa-containing and chocolate products. J. Agric. Food Chem., 2008, 56(18), 8374-8378.
54. Sanders, T. H.; McMichael, R. W., Jr; Hendrix, K. W. Occurrence of resveratrol in edible peanuts. J. Agric. Food Chem., 2000, 48(4), 1243-1246.
55. Sobolev, V. S.; Cole, R. J. trans-resveratrol content in commercial peanuts and peanut products. J. Agric. Food Chem., 1999, 47(4), 1435-1439.
56. Ragab, A. S.; Van Fleet, J.; Jankowski, B.; Park, J-H.; Bob-zin, S. C. Detection and quantitation of resveratrol in tomato fruit (Lycopersicon esculentum Mill.). J. Agric. Food Chem., 2006, 54(19), 7175-7179.
57. Rimando, A. M.; Kalt, W.; Magee, J. B.; Dewey, J.; Balling-ton, J. R. Resveratrol, pterostilbene, and piceatannol in vac-cinium berries. J. Agric. Food Chem., 2004, 52(15), 4713-4719.
58. Wang, S. Y.; Chen, C. T.; Wang, C. Y.; Chen, P. Resveratrol content in strawberry fruit is affected by preharvest conditions. J. Agric. Food Chem., 2007, 55(20), 8269-8274.
59. Wang, Y.; Catana, F.; Yang, Y.; Roderick, R.; van Breemen, R. B. An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J. Agric. Food Chem., 2002, 50(3), 431-435.
60. Hillis, W. E.; Hart, J. H.; Yazaki, Y. Polyphenols of Eucalyptus sideroxylon wood. Phytochemistry, 1974, 13(8), 1591-1595.
61. Rolfs, C. H.; Kindl, H. Stilbene Synthase and Chalcone Synthase: Two Different Constitutive Enzymes in Cultured Cells of Picea excelsa. Plant Physiol., 1984, 75(2), 489-492.
62. Hanawa, F.; Tahara, S.; Mizutani, J. Antifungal stress compounds from Veratrum grandiflorum leaves treated with cu-pric chloride. Phytochemistry, 1992, 31(9), 3005-3007.
63. Vastano, B. C.; Chen, Y.; Zhu, N.; Ho, C. T.; Zhou, Z.; Rosen, R. T. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J. Agric. Food Chem., 2000, 48(2), 253-256.
64. Paul, B.; Masih, I.; Deopujari, J.; Charpentier, C. Occurrence of resveratrol and pterostilbene in age-old darak-chasava, an ayurvedic medicine from India. J. Ethnophar-macol., 1999, 68(1-3), 71-76.
65. Notice, F. G. http://www.fda.gov/downloads/Food/Ingredi-entsPackagingLabeling/GRAS/NoticeInventory/ucm2640-51.pdf, (Accessed 2016-06-26)
66. Almeida, L.; Vaz-da-Silva, M.; Falcão, A.; Soares, E.; Costa, R.; Loureiro, A. I.; Fernandes-Lopes, C.; Rocha, J-F.; Nunes, T.; Wright, L.; Soares-da-Silva, P. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol. Nutr. Food Res., 2009, 53(S1) (Suppl. 1), S7-S15.
67. Brown, V. A.; Patel, K. R.; Viskaduraki, M.; Crowell, J. A.; Perloff, M.; Booth, T. D.; Vasilinin, G.; Sen, A.; Schinas, A. M.; Piccirilli, G.; Brown, K.; Steward, W. P.; Gescher, A. J.; Brenner, D. E. Repeat dose study of the cancer chemo-preventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res., 2010, 70(22), 9003-9011.
68. Panel, E. N. Safety of synthetic trans-resveratrol. EFSA Journal, 2016, 1(14), 30.
69. ®). Ann. N. Y. Acad. Sci., 2011, 1215, 131-137.
70. Kolouchová-Hanzlíková, I.; Melzoch, K.; Filip, V. R.; Šmidrkal, J. Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines. Food Chem., 2004, 87(1), 151-158.
71. Ribeiro de Lima, M. T.; Waffo-Téguo, P.; Teissedre, P. L.; Pujolas, A.; Vercauteren, J.; Cabanis, J. C.; Mérillon, J. M. Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J. Agric. Food Chem., 1999, 47(7), 2666-2670.
72. Potrebko, I.; Resurreccion, A. V. Effect of ultraviolet doses in combined ultraviolet-ultrasound treatments on trans-resveratrol and trans-piceid contents in sliced peanut kernels. J. Agric. Food Chem., 2009, 57(17), 7750-7756.
73. Ibern-Gómez, M.; Roig-Pérez, S.; Lamuela-Raventós, R. M.; de la Torre-Boronat, M. C. Resveratrol and piceid levels in natural and blended peanut butters. J. Agric. Food Chem., 2000, 48(12), 6352-6354.
74. Grippi, F.; Crosta, L.; Aiello, G.; Tolomeo, M.; Oliveri, F.; Gebbia, N.; Curione, A. Determination of stilbenes in Sicilian pistachio by high-performance liquid chromatographic diode array (HPLC-DAD/FLD) and evaluation of eventually mycotoxin contamination. Food Chem., 2008, 107(1), 483-488.
75. Bertelli, A. A.; Giovannini, L.; Stradi, R.; Bertelli, A.; Til-lement, J. P. Plasma, urine and tissue levels of trans- and cis-resveratrol (3, 4, 5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React., 1996, 18(2-3), 67-71.
76. Bertelli, A.; Bertelli, A. A.; Gozzini, A.; Giovannini, L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res., 1998, 24(3), 133-138.
77. Emília Juan, M.; Buenafuente, J.; Casals, I.; Planas, J. M. Plasmatic levels of trans-resveratrol in rats. Food Res. Int., 2002, 35(2-3), 195-199.
78. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; van Breemen, R. B. Human, rat, and mouse metabolism of resveratrol. Pharm. Res., 2002, 19(12), 1907-1914.
79. Marier, J-F.; Vachon, P.; Gritsas, A.; Zhang, J.; Moreau, J-P.; Ducharme, M. P. Metabolism and disposition of resvera-trol in rats: extent of absorption, glucuronidation, and en-terohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther., 2002, 302(1), 369-373.
80. Meng, X.; Maliakal, P.; Lu, H.; Lee, M-J.; Yang, C. S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem., 2004, 52(4), 935-942.
81. Ortuño, J.; Covas, M-I.; Farre, M.; Pujadas, M.; Fito, M.; Khymenets, O.; Andres-Lacueva, C.; Roset, P.; Joglar, J.; Lamuela-Raventós, R. M.; Torre, R.l. Matrix effects on the bioavailability of resveratrol in humans. Food Chem., 2010, 120(4), 1123-1130.
82. Vitaglione, P.; Sforza, S.; Galaverna, G.; Ghidini, C.; Capo-raso, N.; Vescovi, P. P.; Fogliano, V.; Marchelli, R. Bioa-vailability of trans-resveratrol from red wine in humans. Mol. Nutr. Food Res., 2005, 49(5), 495-504.
83. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E., Jr; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos., 2004, 32(12), 1377-1382.
84. Boocock, D. J.; Faust, G. E.; Patel, K. R.; Schinas, A. M.; Brown, V. A.; Ducharme, M. P.; Booth, T. D.; Crowell, J. A.; Perloff, M.; Gescher, A. J.; Steward, W. P.; Brenner, D. E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreven-tive agent. Cancer Epidemiol. Biomarkers Prev., 2007, 16(6), 1246-1252.
85. Zhou, S. F.; Liu, J. P.; Chowbay, B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab. Rev., 2009, 41(2), 89-295.
86. Chang, T. K.; Chen, J.; Lee, W. B. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther., 2001, 299(3), 874-882.
87. Detampel, P.; Beck, M.; Krähenbühl, S.; Huwyler, J. Drug interaction potential of resveratrol. Drug Metab. Rev., 2012, 44(3), 253-265.
88. Goldberg, D. M.; Yan, J.; Soleas, G. J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem., 2003, 36(1), 79-87.
89. Kuhnle, G.; Spencer, J. P.; Chowrimootoo, G.; Schroeter, H.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C.; Hahn, U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun., 2000, 272(1), 212-217.
90. Urpí-Sardà, M.; Jáuregui, O.; Lamuela-Raventós, R. M.; Jaeger, W.; Miksits, M.; Covas, M. I.; Andres-Lacueva, C. Uptake of diet resveratrol into the human low-density lipo-protein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal. Chem., 2005, 77(10), 3149-3155.
91. Jannin, B.; Menzel, M.; Berlot, J. P.; Delmas, D.; Lançon, A.; Latruffe, N. Transport of resveratrol, a cancer chemo-preventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem. Pharmacol., 2004, 68(6), 1113-1118.
92. de Santi, C.; Pietrabissa, A.; Mosca, F.; Pacifici, G. M. Glu-curonidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica, 2000, 30(11), 1047-1054.
93. De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F.; Pacifici, G. M. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xeno-biotica, 2000, 30(6), 609-617.
94. Chow, H. H.; Garland, L. L.; Hsu, C. H.; Vining, D. R.; Chew, W. M.; Miller, J. A.; Perloff, M.; Crowell, J. A.; Alberts, D. S. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. (Phila.), 2010, 3(9), 1168-1175.
95. Hartwell, L. H.; Unger, M. W. Unequal division in Saccha-romyces cerevisiae and its implications for the control of cell division. J. Cell Biol., 1977, 75(2 Pt 1), 422-435.
96. Sinclair, D. A. Paradigms and pitfalls of yeast longevity research. Mech. Ageing Dev., 2002, 123(8), 857-867.
97. Ocampo, A.; Barrientos, A. Quick and reliable assessment of chronological life span in yeast cell populations by flow cytometry. Mech. Ageing Dev., 2011, 132(6-7), 315-323.
98. Kaeberlein, M.; McDonagh, T.; Heltweg, B.; Hixon, J.; Westman, E. A.; Caldwell, S. D.; Napper, A.; Curtis, R.; DiStefano, P. S.; Fields, S.; Bedalov, A.; Kennedy, B. K. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem., 2005, 280(17), 17038-17045.
99. Kennedy, B. K.; Austriaco, N. R. Jr.; Guarente, L. Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span. J. Cell Biol., 1994, 127(6 Pt 2), 1985-1993.
100. Mortimer, R. K.; Johnston, J. R. Life span of individual yeast cells. Nature, 1959, 183(4677), 1751-1752.
101. Howitz, K. T.; Bitterman, K. J.; Cohen, H. Y.; Lamming, D. W.; Lavu, S.; Wood, J. G.; Zipkin, R. E.; Chung, P.; Kisielewski, A.; Zhang, L-L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954), 191-196.
102. Choi, K-M.; Lee, H-L.; Kwon, Y-Y.; Kang, M-S.; Lee, S-K.; Lee, C-K. Enhancement of mitochondrial function correlates with the extension of lifespan by caloric restriction and caloric restriction mimetics in yeast. Biochem. Biophys. Res. Commun., 2013, 441(1), 236-242.
103. Jarolim, S.; Millen, J.; Heeren, G.; Laun, P.; Goldfarb, D. S.; Breitenbach, M. A novel assay for replicative lifespan in Saccharomyces cerevisiae. FEMS Yeast Res., 2004, 5(2), 169-177.
104. Imai, S.; Armstrong, C. M.; Kaeberlein, M.; Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature, 2000, 403(6771), 795-800.
105. Landry, J.; Sutton, A.; Tafrov, S. T.; Heller, R. C.; Stebbins, J.; Pillus, L.; Sternglanz, R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA, 2000, 97(11), 5807-5811.
106. Anderson, R. M.; Bitterman, K. J.; Wood, J. G.; Medvedik, O.; Sinclair, D. A. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cere-visiae. Nature, 2003, 423(6936), 181-185.
107. Wood, J. G.; Rogina, B.; Lavu, S.; Howitz, K.; Helfand, S. L.; Tatar, M.; Sinclair, D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 2004, 430(7000), 686-689.
108. Chen, W.; Rezaizadehnajafi, L.; Wink, M. Influence of resveratrol on oxidative stress resistance and life span in Caenorhabditis elegans. J. Pharm. Pharmacol., 2013, 65(5), 682-688.
109. Zarse, K.; Schmeisser, S.; Birringer, M.; Falk, E.; Schmoll, D.; Ristow, M. Differential effects of resveratrol and SRT1720 on lifespan of adult Caenorhabditis elegans. Horm. Metab. Res., 2010, 42(12), 837-839.
110. Ye, K.; Ji, C-B.; Lu, X. W.; Ni, Y. H.; Gao, C. L.; Chen, X. H.; Zhao, Y. P.; Gu, G. X.; Guo, X. R. Resveratrol attenuates radiation damage in Caenorhabditis elegans by preventing oxidative stress. J. Radiat. Res. (Tokyo), 2010, 51(4), 473-479.
111. Viswanathan, M.; Kim, S. K.; Berdichevsky, A.; Guarente, L. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell, 2005, 9(5), 605-615.
112. Greer, E. L.; Brunet, A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell, 2009, 8(2), 113-127.
113. Gruber, J.; Tang, S. Y.; Halliwell, B. Evidence for a tradeoff between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann. N. Y. Acad. Sci., 2007, 1100, 530-542.
114. Bitterman, K. J.; Medvedik, O.; Sinclair, D. A. Longevity regulation in Saccharomyces cerevisiae: linking metabolism, genome stability, and heterochromatin. Microbiol. Mol. Biol. Rev., 2003, 67(3), 376-399.
115. Sunagawa, T.; Shimizu, T.; Kanda, T.; Tagashira, M.; Sami, M.; Shirasawa, T. Procyanidins from apples (Malus pumila Mill.) extend the lifespan of Caenorhabditis elegans. Planta Med., 2011, 77(2), 122-127.
116. Bass, T. M.; Weinkove, D.; Houthoofd, K.; Gems, D.; Partridge, L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev., 2007, 128(10), 546-552.
117. Urano, F.; Calfon, M.; Yoneda, T.; Yun, C.; Kiraly, M.; Clark, S. G.; Ron, D. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. J. Cell Biol., 2002, 158(4), 639-646.
118. Morselli, E.; Maiuri, M. C.; Markaki, M.; Megalou, E.; Pas-paraki, A.; Palikaras, K.; Criollo, A.; Galluzzi, L.; Malik, S. A.; Vitale, I.; Michaud, M.; Madeo, F.; Tavernarakis, N.; Kroemer, G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of au-tophagy. Cell Death Dis., 2010, 1, e10.
119. Liang, X. H.; Jackson, S.; Seaman, M.; Brown, K.; Kemp-kes, B.; Hibshoosh, H.; Levine, B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999, 402(6762), 672-676.
120. Apfeld, J.; OConnor, G.; McDonagh, T.; DiStefano, P. S.; Curtis, R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. ele-gans. Genes Dev., 2004, 18(24), 3004-3009.
121. Ishii, N.; Fujii, M.; Hartman, P. S.; Tsuda, M.; Yasuda, K.; Senoo-Matsuda, N.; Yanase, S.; Ayusawa, D.; Suzuki, K. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature, 1998, 394(6694), 694-697.
122. McCormack, S.; Polyak, E.; Ostrovsky, J.; Dingley, S. D.; Rao, M.; Kwon, Y. J.; Xiao, R.; Zhang, Z.; Nakamaru-Ogiso, E.; Falk, M. J. Pharmacologic targeting of sirtuin and PPAR signaling improves longevity and mitochondrial physiology in respiratory chain complex I mutant Caeno-rhabditis elegans. Mitochondrion, 2015, 22, 45-59.
123. Wang, C.; Wheeler, C. T.; Alberico, T.; Sun, X.; Seeberger, J.; Laslo, M.; Spangler, E.; Kern, B.; de Cabo, R.; Zou, S. The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melano-gaster. Age (Dordr.), 2013, 35(1), 69-81.
124. Bauer, J. H.; Goupil, S.; Garber, G. B.; Helfand, S. L. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA, 2004, 101(35), 12980-12985.
125. Zou, S.; Carey, J. R.; Liedo, P.; Ingram, D. K.; Müller, H-G.; Wang, J-L.; Yao, F.; Yu, B.; Zhou, A. The prolongevity effect of resveratrol depends on dietary composition and calorie intake in a tephritid fruit fly. Exp. Gerontol., 2009, 44(6-7), 472-476.
126. Chandrashekara, K. T.; Shakarad, M. N. Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fly, Drosophila melanogaster. J. Gerontol. A Bi-ol. Sci. Med. Sci., 2011, 66(9), 965-971.
127. Rascón, B.; Hubbard, B. P.; Sinclair, D. A.; Amdam, G. V. The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging (Albany, N. Y.), 2012, 4(7), 499-508.
128. Costa, C.; Lodesani, M.; Maistrello, L. Effect of thymol and resveratrol administered with candy or syrup on the development of Nosema ceranaeand on the longevity of honeybees (Apis melliferaL.) in laboratory conditions. Apidologie (Celle), 2010, 41(2), 141-150.
129. Johnson, A. A.; Riehle, M. A. Resveratrol fails to extend lifespan in the mosquito Anopheles stephensi. Rejuvenation Res., 2015, 18(5), 473-478.
130. Valenzano, D. R.; Terzibasi, E.; Genade, T.; Cattaneo, A.; Domenici, L.; Cellerino, A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol., 2006, 16(3), 296-300.
131. Valdesalici, S.; Cellerino, A. Extremely short lifespan in the annual fish Nothobranchius furzeri. 2003, 270(Suppl 2):S189-S191.
132. Genade, T.; Lang, D. M. Resveratrol extends lifespan and preserves glia but not neurons of the Nothobranchius guen-theri optic tectum. Exp. Gerontol., 2013, 48(2), 202-212.
133. Yu, X.; Li, G. Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri. Exp. Gerontol., 2012, 47(12), 940-949.
134. Kim, E.; Ansell, C. M.; Dudycha, J. L. Resveratrol and food effects on lifespan and reproduction in the model crustacean Daphnia. J. Exp. Zool. A. Ecol. Genet. Physiol., 2014, 321(1), 48-56.
135. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Ler-in, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G.; Le Couteur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram, D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444(7117), 337-342.
136. Pearson, K. J.; Baur, J. A.; Lewis, K. N.; Peshkin, L.; Price, N. L.; Labinskyy, N.; Swindell, W. R.; Kamara, D.; Minor, R. K.; Perez, E.; Jamieson, H. A.; Zhang, Y.; Dunn, S. R.; Sharma, K.; Pleshko, N.; Woollett, L. A.; Csiszar, A.; Ikeno, Y.; Le Couteur, D.; Elliott, P. J.; Becker, K. G.; Navas, P.; Ingram, D. K.; Wolf, N. S.; Ungvari, Z.; Sinclair, D. A.; de Cabo, R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab., 2008, 8(2), 157-168.
137. Strong, R.; Miller, R. A.; Astle, C. M.; Baur, J. A.; de Cabo, R.; Fernandez, E.; Guo, W.; Javors, M.; Kirkland, J. L.; Nelson, J. F.; Sinclair, D. A.; Teter, B.; Williams, D.; Zaveri, N.; Nadon, N. L.; Harrison, D. E. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci., 2013, 68(1), 6-16.
138. Miller, R. A.; Harrison, D. E.; Astle, C. M.; Baur, J. A.; Boyd, A. R.; de Cabo, R.; Fernandez, E.; Flurkey, K.; Javors, M. A.; Nelson, J. F.; Orihuela, C. J.; Pletcher, S.; Sharp, Z. D.; Sinclair, D.; Starnes, J. W.; Wilkinson, J. E.; Nadon, N. L.; Strong, R. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Ger-ontol. A Biol. Sci. Med. Sci., 2011, 66(2), 191-201.
139. da Luz, P. L.; Tanaka, L.; Brum, P. C.; Dourado, P. M.; Fava-rato, D.; Krieger, J. E.; Laurindo, F. R. Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats. Atherosclerosis, 2012, 224(1), 136-142.
140. Mulvey, L.; Sinclair, A.; Selman, C. Lifespan modulation in mice and the confounding effects of genetic background. J. Genet. Genomics., 2014, 41(9), 497-503.
141. Hegde, R.; Srinivasula, S. M.; Zhang, Z.; Wassell, R.; Muk-attash, R.; Cilenti, L.; DuBois, G.; Lazebnik, Y.; Zervos, A. S.; Fernandes-Alnemri, T.; Alnemri, E. S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 2002, 277(1), 432-438.
142. Kilbride, S. M.; Prehn, J. H. Central roles of apoptotic proteins in mitochondrial function. Oncogene, 2013, 32(22), 2703-2711.
143. Gerhardt, E.; Gräber, S.; Szego, É. M.; Moisoi, N.; Martins, L. M.; Outeiro, T. F.; Kermer, P. Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS One, 2011, 6(12), e28855.
144. Mancuso, R.; del Valle, J.; Modol, L.; Martinez, A.; Grana-do-Serrano, A. B.; Ramirez-Núñez, O.; Pallás, M.; Portero-Otin, M.; Osta, R.; Navarro, X. Resveratrol improves moto-neuron function and extends survival in SOD1 (G93A) ALS mice. Neurotherapeutics, 2014, 11(2), 419-432.
145. Song, L.; Chen, L.; Zhang, X.; Li, J.; Le, W. Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. BioMed. Res. Int., 2014, 2014, 1-10.
146. Porquet, D.; Casadesús, G.; Bayod, S.; Vicente, A.; Canudas, A. M.; Vilaplana, J.; Pelegrí, C.; Sanfeliu, C.; Camins, A.; Pallàs, M.; del Valle, J. Dietary resveratrol prevents Alzheimers markers and increases life span in SAMP8. Age (Dordr.), 2013, 35(5), 1851-1865.
147. Labbé, A.; Garand, C.; Cogger, V. C.; Paquet, E. R.; Des-biens, M.; Le Couteur, D. G.; Lebel, M. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome. J. Gerontol. A Biol. Sci. Med. Sci., 2011, 66(3), 264-278.
148. Yoshino, J.; Conte, C.; Fontana, L.; Mittendorfer, B.; Imai, S.; Schechtman, K. B.; Gu, C.; Kunz, I.; Rossi Fanelli, F.; Patterson, B. W.; Klein, S. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab., 2012, 16(5), 658-664.
149. Poulsen, M. M.; Vestergaard, P. F.; Clasen, B. F.; Radko, Y.; Christensen, L. P.; Stødkilde-Jørgensen, H.; Møller, N.; Jessen, N.; Pedersen, S. B.; Jørgensen, J. O. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes, 2013, 62(4), 1186-1195.
150. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R. H.; van de Weijer, T.; Goossens, G. H.; Hoeks, J.; van der Krieken, S.; Ryu, D.; Kersten, S.; Moonen-Kornips, E.; Hesselink, M. K.; Kunz, I.; Schrauwen-Hinderling, V. B.; Blaak, E. E.; Auwerx, J.; Schrauwen, P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab., 2011, 14(5), 612-622.
151. Gualdoni, G. A.; Kovarik, J. J.; Hofer, J.; Dose, F.; Pignitter, M.; Doberer, D.; Steinberger, P.; Somoza, V.; Wolzt, M.; Zlabinger, G. J. Resveratrol enhances TNF-a production in human monocytes upon bacterial stimulation. Biochim. Bi-ophys. Acta, 2014, 1840(1), 95-105.
152. Holzenberger, M.; Dupont, J.; Ducos, B.; Leneuve, P.; Gé-loën, A.; Even, P. C.; Cervera, P.; Le Bouc, Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature, 2003, 421(6919), 182-187.
153. Broughton, S. J.; Piper, M. D.; Ikeya, T.; Bass, T. M.; Jacob-son, J.; Driege, Y.; Martinez, P.; Hafen, E.; Withers, D. J.; Leevers, S. J.; Partridge, L. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc. Natl. Acad. Sci. USA, 2005, 102(8), 3105-3110.
154. Kimura, K. D.; Tissenbaum, H. A.; Liu, Y.; Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science, 1997, 277(5328), 942-946.
155. Pawlikowska, L.; Hu, D.; Huntsman, S.; Sung, A.; Chu, C.; Chen, J.; Joyner, A. H.; Schork, N. J.; Hsueh, W-C.; Reiner, A. P.; Psaty, B. M.; Atzmon, G.; Barzilai, N.; Cummings, S. R.; Browner, W. S.; Kwok, P-Y.; Ziv, E. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell, 2009, 8(4), 460-472.
156. Chiba, T.; Kimura, Y.; Suzuki, S.; Tatefuji, T.; Umegaki, K. Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model. J. Atheroscler. Thromb., 2016, 23(9), 1099-1110.
157. Brasnyó, P.; Molnár, G. A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mikolás, E.; Szijártó, I. A.; Mérei, A.; Halmai, R.; Mészáros, L. G.; Sümegi, B.; Wittmann, I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr., 2011, 106(3), 383-389.
158. Wong, R. H.; Howe, P. R.; Buckley, J. D.; Coates, A. M.; Kunz, I.; Berry, N. M. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis., 2011, 21(11), 851-856.
159. Crandall, J. P.; Oram, V.; Trandafirescu, G.; Reid, M.; Kishore, P.; Hawkins, M.; Cohen, H. W.; Barzilai, N. Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci., 2012, 67(12), 1307-1312.
160. Magyar, K.; Halmosi, R.; Palfi, A.; Feher, G.; Czopf, L.; Fulop, A.; Battyany, I.; Sumegi, B.; Toth, K.; Szabados, E. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin. Hem-orheol. Microcirc., 2012, 50(3), 179-187.
161. Bhatt, J. K.; Thomas, S.; Nanjan, M. J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res., 2012, 32(7), 537-541.
162. Bo, S.; Ciccone, G.; Castiglione, A.; Gambino, R.; De Michieli, F.; Villois, P.; Durazzo, M.; Cavallo-Perin, P.; Cassader, M. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr. Med. Chem., 2013, 20(10), 1323-1331.
163. Knop, F. K.; Konings, E.; Timmers, S.; Schrauwen, P.; Holst, J. J.; Blaak, E. E. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabet. Med., 2013, 30(10), 1214-1218.
164. Wong, R. H.; Berry, N. M.; Coates, A. M.; Buckley, J. D.; Bryan, J.; Kunz, I.; Howe, P. R. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J. Hypertens., 2013, 31(9), 1819-1827.
165. Gliemann, L.; Schmidt, J. F.; Olesen, J.; Biensø, R. S.; Pe-ronard, S. L.; Grandjean, S. U.; Mortensen, S. P.; Nyberg, M.; Bangsbo, J.; Pilegaard, H.; Hellsten, Y. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J. Physiol., 2013, 591(20), 5047-5059.
166. Goh, K. P.; Lee, H. Y.; Lau, D. P.; Supaat, W.; Chan, Y. H.; Koh, A. F. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. Int. J. Sport Nutr. Exerc. Metab., 2014, 24(1), 2-13.
167. Konings, E.; Timmers, S.; Boekschoten, M. V.; Goossens, G. H.; Jocken, J. W.; Afman, L. A.; Müller, M.; Schrauwen, P.; Mariman, E. C.; Blaak, E. E. The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. Int. J. Obes., 2014, 38(3), 470-473.
168. Dash, S.; Xiao, C.; Morgantini, C.; Szeto, L.; Lewis, G. F. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. Arterioscler. Thromb. Vasc. Biol., 2013, 33(12), 2895-2901.
169. Chachay, V. S.; Macdonald, G. A.; Martin, J. H.; White-head, J. P.; O'Moore-Sullivan, T. M.; Lee, P.; Franklin, M.; Klein, K.; Taylor, P. J.; Ferguson, M.; Coombes, J. S.; Thomas, G. P.; Cowin, G. J.; Kirkpatrick, C. M.; Prins, J. B.; Hickman, I. J. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepa-tol., 2014, 12(12), 2092-2103, e1-e6.
170. Anton, S. D.; Embry, C.; Marsiske, M.; Lu, X.; Doss, H.; Leeuwenburgh, C.; Manini, T. M. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp. Ger-ontol., 2014, 57, 181-187.
171. Williams, C. B.; Hughes, M. C.; Edgett, B. A.; Scribbans, T. D.; Simpson, C. A.; Perry, C. G.; Gurd, B. J. An examination of resveratrols mechanisms of action in human tissue: impact of a single dose in vivo and dose responses in skeletal muscle ex vivo. PLoS One, 2014, 9(7), e102406.
172. Méndez-del Villar, M.; González-Ortiz, M.; Martínez-Abundis, E.; Pérez-Rubio, K. G.; Lizárraga-Valdez, R. Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab. Syndr. Relat. Disord., 2014, 12(10), 497-501.
173. Faghihzadeh, F.; Adibi, P.; Rafiei, R.; Hekmatdoost, A. Resveratrol supplementation improves inflammatory bi-omarkers in patients with nonalcoholic fatty liver disease. Nutr. Res., 2014, 34(10), 837-843.
174. Macedo, R. C.; Vieira, A.; Marin, D. P.; Otton, R. Effects of chronic resveratrol supplementation in military firefighters undergo a physical fitness testa placebo-controlled, double blind study. Chem. Biol. Interact., 2015, 227, 89-95.
175. Chen, S.; Zhao, X.; Ran, L.; Wan, J.; Wang, X.; Qin, Y.; Shu, F.; Gao, Y.; Yuan, L.; Zhang, Q.; Mi, M. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig. Liver Dis., 2015, 47(3), 226-232.
176. van der Made, S. M.; Plat, J.; Mensink, R. P. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One, 2015, 10(3), e0118393.
177. Samsami-Kor, M.; Daryani, N. E.; Asl, P. R.; Hekmatdoost, A. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Arch. Med. Res., 2015, 46(4), 280-285.
178. Faghihzadeh, F.; Adibi, P.; Hekmatdoost, A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br. J. Nutr., 2015, 114(5), 796-803.
179. Thazhath, S. S.; Wu, T.; Bound, M. J.; Checklin, H. L.; Standfield, S.; Jones, K. L.; Horowitz, M.; Rayner, C. K. Administration of resveratrol for 5 wk has no effect on glu-cagon-like peptide 1 secretion, gastric emptying, or glyce-mic control in type 2 diabetes: a randomized controlled trial. Am. J. Clin. Nutr., 2016, 103(1), 66-70.
180. Marchal, J.; Pifferi, F.; Aujard, F. Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span. Ann. N. Y. Acad. Sci., 2013, 1290(1), 67-73.
181. Valenzano, D. R.; Cellerino, A. Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle, 2006, 5(10), 1027-1032.
182. Calabrese, E. J.; Bachmann, K. A.; Bailer, A. J.; Bolger, P. M.; Borak, J.; Cai, L.; Cedergreen, N.; Cherian, M. G.; Chiueh, C. C.; Clarkson, T. W.; Cook, R. R.; Diamond, D. M.; Doolittle, D. J.; Dorato, M. A.; Duke, S. O.; Feinendegen, L.; Gardner, D. E.; Hart, R. W.; Hastings, K. L.; Hayes, A. W.; Hoffmann, G. R.; Ives, J. A.; Jaworowski, Z.; Johnson, T. E.; Jonas, W. B.; Kaminski, N. E.; Keller, J. G.; Klaunig, J. E.; Knudsen, T. B.; Kozumbo, W. J.; Lettieri, T.; Liu, S-Z.; Maisseu, A.; Maynard, K. I.; Masoro, E. J.; McClellan, R. O.; Mehendale, H. M.; Mothersill, C.; Newlin, D. B.; Nigg, H. N.; Oehme, F. W.; Phalen, R. F.; Philbert, M. A.; Rattan, S. I.; Riviere, J. E.; Rodricks, J.; Sapolsky, R. M.; Scott, B. R.; Seymour, C.; Sinclair, D. A.; Smith-Sonneborn, J.; Snow, E. T.; Spear, L.; Stevenson, D. E.; Thomas, Y.; Tubiana, M.; Williams, G. M.; Mattson, M. P. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol. Appl. Pharmacol., 2007, 222(1), 122-128.
183. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jimé-nez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
184. Frye, R. A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun., 2000, 273(2), 793-798.
185. Breen, D. M.; Sanli, T.; Giacca, A.; Tsiani, E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem. Biophys. Res. Commun., 2008, 374(1), 117-122.
186. Danz, E. D.; Skramsted, J.; Henry, N.; Bennett, J. A.; Keller, R. S. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic. Biol. Med., 2009, 46(12), 1589-1597.
187. Kao, C-L.; Chen, L-K.; Chang, Y-L.; Yung, M-C.; Hsu, C-C.; Chen, Y-C.; Lo, W-L.; Chen, S-J.; Ku, H-H.; Hwang, S-J. Resveratrol protects human endothelium from H (2) O (2)-induced oxidative stress and senescence via SirT1 activation. J. Atheroscler. Thromb., 2010, 17(9), 970-979.
188. Pacholec, M.; Bleasdale, J. E.; Chrunyk, B.; Cunningham, D.; Flynn, D.; Garofalo, R. S.; Griffith, D.; Griffor, M.; Lou-lakis, P.; Pabst, B.; Qiu, X.; Stockman, B.; Thanabal, V.; Varghese, A.; Ward, J.; Withka, J.; Ahn, K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem., 2010, 285(11), 8340-8351.
189. Beher, D.; Wu, J.; Cumine, S.; Kim, K. W.; Lu, S. C.; Atan-gan, L.; Wang, M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des., 2009, 74(6), 619-624.
190. Sajish, M.; Schimmel, P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature, 2015, 519(7543), 370-373.
191. Salminen, A.; Kaarniranta, K. AMP-activated protein ki-nase (AMPK) controls the aging process via an integrated signaling network. Ageing Res. Rev., 2012, 11(2), 230-241.
192. Hardie, D. G.; Carling, D. The AMP-activated protein ki-nasefuel gauge of the mammalian cell? Eur. J. Biochem., 1997, 246(2), 259-273.
193. Chan, A. Y.; Dolinsky, V. W.; Soltys, C. L.; Viollet, B.; Baksh, S.; Light, P. E.; Dyck, J. R. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J. Biol. Chem., 2008, 283(35), 24194-24201.
194. Park, C. E.; Kim, M-J.; Lee, J. H.; Min, B-I.; Bae, H.; Choe, W.; Kim, S-S.; Ha, J. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med., 2007, 39(2), 222-229.
195. Dasgupta, B.; Milbrandt, J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA, 2007, 104(17), 7217-7222.
196. Cantó, C.; Jiang, L. Q.; Deshmukh, A. S.; Mataki, C.; Coste, A.; Lagouge, M.; Zierath, J. R.; Auwerx, J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab., 2010, 11(3), 213-219.
197. Park, S-J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A. L.; Kim, M. K.; Beaven, M. A.; Burgin, A. B.; Manganiello, V.; Chung, J. H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell, 2012, 148(3), 421-433.
198. Um, J-H.; Park, S-J.; Kang, H.; Yang, S.; Foretz, M.; McBurney, M. W.; Kim, M. K.; Viollet, B.; Chung, J. H. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes, 2010, 59(3), 554-563.
199. Kaestner, K. H.; Knochel, W.; Martinez, D. E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev., 2000, 14(2), 142-146.
200. Greer, E. L.; Brunet, A. FOXO transcription factors at the interface between longevity and tumor suppression. Onco-gene, 2005, 24(50), 7410-7425.
201. Imae, M.; Fu, Z.; Yoshida, A.; Noguchi, T.; Kato, H. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J. Mol. Endocrinol., 2003, 30(2), 253-262.
202. Brunet, A.; Bonni, A.; Zigmond, M. J.; Lin, M. Z.; Juo, P.; Hu, L. S.; Anderson, M. J.; Arden, K. C.; Blenis, J.; Green-berg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 1999, 96(6), 857-868.
203. Kops, G. J.; Medema, R. H.; Glassford, J.; Essers, M. A.; Dijkers, P. F.; Coffer, P. J.; Lam, E. W.; Burgering, B. M. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol., 2002, 22(7), 2025-2036.
204. Murphy, C. T.; McCarroll, S. A.; Bargmann, C. I.; Fraser, A.; Kamath, R. S.; Ahringer, J.; Li, H.; Kenyon, C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature, 2003, 424(6946), 277-283.
205. Tran, H.; Brunet, A.; Grenier, J. M.; Datta, S. R.; Fornace, A. J., Jr; DiStefano, P. S.; Chiang, L. W.; Greenberg, M. E. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science, 2002, 296(5567), 530-534.
206. Yen, W. L.; Klionsky, D. J. How to live long and prosper: autophagy, mitochondria, and aging. Physiology (Bethes-da), 2008, 23, 248-262.
207. Zhao, J.; Brault, J. J.; Schild, A.; Cao, P.; Sandri, M.; Schi-affino, S.; Lecker, S. H.; Goldberg, A. L. FoxO3 coordinate-ly activates protein degradation by the autophag-ic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab., 2007, 6(6), 472-483.
208. Hwangbo, D. S.; Gershman, B.; Tu, M. P.; Palmer, M.; Tatar, M.; Tatar, M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature, 2004, 429(6991), 562-566.
209. Ogg, S.; Paradis, S.; Gottlieb, S.; Patterson, G. I.; Lee, L.; Tissenbaum, H. A.; Ruvkun, G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C.elegans. Nature, 1997, 389(6654), 994-999.
210. Greer, E. L.; Oskoui, P. R.; Banko, M. R.; Maniar, J. M.; Gygi, M. P.; Gygi, S. P.; Brunet, A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem., 2007, 282(41), 30107-30119.
211. Brunet, A.; Sweeney, L. B.; Sturgill, J. F.; Chua, K. F.; Greer, P. L.; Lin, Y.; Tran, H.; Ross, S. E.; Mostoslavsky, R.; Cohen, H. Y.; Hu, L. S.; Cheng, H-L.; Jedrychowski, M. P.; Gygi, S. P.; Sinclair, D. A.; Alt, F. W.; Greenberg, M. E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 2004, 303(5666), 2011-2015.
212. Stefani, M.; Markus, M. A.; Lin, R. C.; Pinese, M.; Dawes, I. W.; Morris, B. J. The effect of resveratrol on a cell model of human aging. Ann. N. Y. Acad. Sci., 2007, 1114, 407-418.
213. Van Der Heide, L. P.; Hoekman, M. F.; Smidt, M. P. The ins and outs of FoxO shuttling: mechanisms of FoxO transloca-tion and transcriptional regulation. Biochem. J., 2004, 380(Pt 2), 297-309.
214. Asada, S.; Daitoku, H.; Matsuzaki, H.; Saito, T.; Sudo, T.; Mukai, H.; Iwashita, S.; Kako, K.; Kishi, T.; Kasuya, Y.; Fukamizu, A. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal., 2007, 19(3), 519-527.
215. Yang, J. Y.; Zong, C. S.; Xia, W.; Yamaguchi, H.; Ding, Q.; Xie, X.; Lang, J. Y.; Lai, C. C.; Chang, C. J.; Huang, W. C.; Huang, H.; Kuo, H. P.; Lee, D. F.; Li, L. Y.; Lien, H. C.; Cheng, X.; Chang, K. J.; Hsiao, C. D.; Tsai, F. J.; Tsai, C. H.; Sahin, A. A.; Muller, W. J.; Mills, G. B.; Yu, D.; Hortobagyi, G. N.; Hung, M. C. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol., 2008, 10(2), 138-148.
216. Roy, S. K.; Chen, Q.; Fu, J.; Shankar, S.; Srivastava, R. K. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One, 2011, 6(9), e25166.
217. Puigserver, P.; Spiegelman, B. M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev., 2003, 24(1), 78-90.
218. Vega, R. B.; Huss, J. M.; Kelly, D. P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Bi-ol., 2000, 20(5), 1868-1876.
219. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R. C.; Spiegelman, B. M. Mechanisms controlling mitochondrial biogenesis and respiration through the ther-mogenic coactivator PGC-1. Cell, 1999, 98(1), 115-124.
220. St-Pierre, J.; Drori, S.; Uldry, M.; Silvaggi, J. M.; Rhee, J.; Jäger, S.; Handschin, C.; Zheng, K.; Lin, J.; Yang, W.; Simon, D. K.; Bachoo, R.; Spiegelman, B. M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 2006, 127(2), 397-408.
221. Anderson, R. M.; Barger, J. L.; Edwards, M. G.; Braun, K. H.; OConnor, C. E.; Prolla, T. A.; Weindruch, R. Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell, 2008, 7(1), 101-111.
222. Trifunovic, A.; Larsson, N. G. Mitochondrial dysfunction as a cause of ageing. J. Intern. Med., 2008, 263(2), 167-178.
223. Karamitri, A.; Shore, A. M.; Docherty, K.; Speakman, J. R.; Lomax, M. A. Combinatorial transcription factor regulation of the cyclic AMP-response element on the Pgc-1alpha promoter in white 3T3-L1 and brown HIB-1B preadipo-cytes. J. Biol. Chem., 2009, 284(31), 20738-20752.
224. Selawry, H.; Gutman, R.; Fink, G.; Recant, L. The effect of starvation on tissue adenosine 35 monophosphate levels. Biochem. Biophys. Res. Commun., 1973, 51(1), 198-204.
225. Szkudelska, K.; Nogowski, L.; Szkudelski, T. Resveratrol, a naturally occurring diphenolic compound, affects lipogene-sis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol., 2009, 113(1-2), 17-24.
226. Shin, S. M.; Cho, I. J.; Kim, S. G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly (ADP-ribose) polymerase-LKB1 pathway. Mol. Pharmacol., 2009, 76(4), 884-895.
227. Jäger, S.; Handschin, C.; St-Pierre, J.; Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA, 2007, 104(29), 12017-12022.
228. Rodgers, J. T.; Lerin, C.; Haas, W.; Gygi, S. P.; Spiegelman, B. M.; Puigserver, P. Nutrient control of glucose homeosta-sis through a complex of PGC-1alpha and SIRT1. Nature, 2005, 434(7029), 113-118.
229. Price, N. L.; Gomes, A. P.; Ling, A. J.; Duarte, F. V.; Martin-Montalvo, A.; North, B. J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J. S.; Hubbard, B. P.; Varela, A. T.; Davis, J. G.; Varamini, B.; Hafner, A.; Moaddel, R.; Rolo, A. P.; Cop-pari, R.; Palmeira, C. M.; de Cabo, R.; Baur, J. A.; Sinclair, D. A. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab., 2012, 15(5), 675-690.
230. Csiszar, A.; Labinskyy, N.; Pinto, J. T.; Ballabh, P.; Zhang, H.; Losonczy, G.; Pearson, K.; de Cabo, R.; Pacher, P.; Zhang, C.; Ungvari, Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 2009, 297(1), H13-H20.
231. Patel, M. I.; Gupta, A.; Dey, C. S. Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK. Pharmacol. Rep., 2011, 63(5), 1162-1168.
232. Chen, L. L.; Zhang, H-H.; Zheng, J.; Hu, X.; Kong, W.; Hu, D.; Wang, S. X.; Zhang, P. Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation. Metabolism, 2011, 60(11), 1598-1609.
233. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127(6), 1109-1122.
234. Blüher, M.; Kahn, B. B.; Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science, 2003, 299(5606), 572-574.
235. Ruggeri, B. A.; Klurfeld, D. M.; Kritchevsky, D.; Furlanetto, R. W. Caloric restriction and 7, 12-dimethylbenz (a) anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res., 1989, 49(15), 4130-4134.
236. Argentino, D. P.; Dominici, F. P.; Al-Regaiey, K.; Bonkow-ski, M. S.; Bartke, A.; Turyn, D. Effects of long-term caloric restriction on early steps of the insulin-signaling system in mouse skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci., 2005, 60(1), 28-34.
237. Fröjdö, S.; Cozzone, D.; Vidal, H.; Pirola, L. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem. J., 2007, 406(3), 511-518.
238. Zhang, J. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J., 2006, 397(3), 519-527.
239. Vanamala, J.; Reddivari, L.; Radhakrishnan, S.; Tarver, C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer, 2010, 10, 238.
240. Ma, J.; Pollak, M. N.; Giovannucci, E.; Chan, J. M.; Tao, Y.; Hennekens, C. H.; Stampfer, M. J. Prospective study of colo-rectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst., 1999, 91(7), 620-625.
241. Bagul, P. K.; Middela, H.; Matapally, S.; Padiya, R.; Bastia, T.; Madhusudana, K.; Reddy, B. R.; Chakravarty, S.; Banerjee, S. K. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol. Res., 2012, 66(3), 260-268.
242. Burgess, T. A.; Robich, M. P.; Chu, L. M.; Bianchi, C.; Sell-ke, F. W. Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle. Arch. Surg., 2011, 146(5), 556-564.
243. Rivera, L.; Morón, R.; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Bio-chem. Pharmacol., 2009, 77(6), 1053-1063.
244. Deng, J. Y.; Hsieh, P. S.; Huang, J. P.; Lu, L. S.; Hung, L. M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes, 2008, 57(7), 1814-1823.
245. Elliott, P. J.; Walpole, S.; Morelli, L.; Lambert, P. D.; Lunsmann, W.; Westphal, C. H.; Lavu, S. Resveratrol/SRT-501. Drugs Future, 2009, 34(4), 291.
246. Blackburn, E. H. Structure and function of telomeres. Nature, 1991, 350(6319), 569-573.
247. Nakamura, T. M.; Morin, G. B.; Chapman, K. B.; Weinrich, S. L.; Andrews, W. H.; Lingner, J.; Harley, C. B.; Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997, 277(5328), 955-959.
248. Harley, C. B.; Vaziri, H.; Counter, C. M.; Allsopp, R. C. The telomere hypothesis of cellular aging. Exp. Gerontol., 1992, 27(4), 375-382.
249. Kruk, P. A.; Rampino, N. J.; Bohr, V. A. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. USA, 1995, 92(1), 258-262.
250. Hackett, J. A.; Feldser, D. M.; Greider, C. W. Telomere dysfunction increases mutation rate and genomic instability. Cell, 2001, 106(3), 275-286.
251. Ahmed, S.; Passos, J. F.; Birket, M. J.; Beckmann, T.; Brings, S.; Peters, H.; Birch-Machin, M. A.; von Zglinicki, T.; Saretzki, G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxida-tive stress. J. Cell Sci., 2008, 121(Pt 7), 1046-1053.
252. Masutomi, K.; Possemato, R.; Wong, J. M.; Currier, J. L.; Tothova, Z.; Manola, J. B.; Ganesan, S.; Lansdorp, P. M.; Collins, K.; Hahn, W. C. The telomerase reverse transcrip-tase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA, 2005, 102(23), 8222-8227.
253. Xia, L.; Wang, X. X.; Hu, X. S.; Guo, X. G.; Shang, Y. P.; Chen, H. J.; Zeng, C. L.; Zhang, F. R.; Chen, J. Z. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br. J. Pharmacol., 2008, 155(3), 387-394.
254. Uchiumi, F.; Watanabe, T.; Hasegawa, S.; Hoshi, T.; Hi-gami, Y.; Tanuma, S. The effect of resveratrol on the Werner syndrome RecQ helicase gene and telomerase activity. Curr. Aging Sci., 2011, 4(1), 1-7.
255. Kim, N. W.; Piatyszek, M. A.; Prowse, K. R.; Harley, C. B.; West, M. D.; Ho, P. L.; Coviello, G. M.; Wright, W. E.; Wein-rich, S. L.; Shay, J. W. Specific association of human te-lomerase activity with immortal cells and cancer. Science, 1994, 266(5193), 2011-2015.
256. Fuggetta, M. P.; Lanzilli, G.; Tricarico, M.; Cottarelli, A.; Falchetti, R.; Ravagnan, G.; Bonmassar, E. Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. J. Exp. Clin. Cancer Res., 2006, 25(2), 189-193.
257. Lanzilli, G.; Fuggetta, M. P.; Tricarico, M.; Cottarelli, A.; Serafino, A.; Falchetti, R.; Ravagnan, G.; Turriziani, M.; Adamo, R.; Franzese, O.; Bonmassar, E. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int. J. Oncol., 2006, 28(3), 641-648.
258. Touyz, R. M.; Schiffrin, E. L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev., 2000, 52(4), 639-672.
259. Sasaki, K.; Yamano, Y.; Bardhan, S.; Iwai, N.; Murray, J. J.; Hasegawa, M.; Matsuda, Y.; Inagami, T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature, 1991, 351(6323), 230-233.
260. Kambayashi, Y.; Bardhan, S.; Takahashi, K.; Tsuzuki, S.; Inui, H.; Hamakubo, T.; Inagami, T. Molecular cloning of a novel angiotensin II receptor isoform involved in phos-photyrosine phosphatase inhibition. J. Biol. Chem., 1993, 268(33), 24543-24546.
261. Herbert, K. E.; Mistry, Y.; Hastings, R.; Poolman, T.; Nikla-son, L.; Williams, B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ. Res., 2008, 102(2), 201-208.
262. Linz, W.; Heitsch, H.; Schölkens, B. A.; Wiemer, G. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension, 2000, 35(4), 908-913.
263. Benigni, A.; Corna, D.; Zoja, C.; Sonzogni, A.; Latini, R.; Salio, M.; Conti, S.; Rottoli, D.; Longaretti, L.; Cassis, P.; Morigi, M.; Coffman, T. M.; Remuzzi, G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest., 2009, 119(3), 524-530.
264. Miyazaki, R.; Ichiki, T.; Hashimoto, T.; Inanaga, K.; Ima-yama, I.; Sadoshima, J.; Sunagawa, K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 2008, 28(7), 1263-1269.
265. Ichiki, T.; Miyazaki, R.; Kamiharaguchi, A.; Hashimoto, T.; Matsuura, H.; Kitamoto, S.; Tokunou, T.; Sunagawa, K. Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells. Regul. Pept., 2012, 177(1-3), 35-39.
266. Cuervo, A. M. Autophagy and aging: keeping that old broom working. Trends Genet., 2008, 24(12), 604-612.
267. Levine, B.; Klionsky, D. J. Development by self-digestion: molecular mechanisms and biological functions of autopha-gy. Dev. Cell, 2004, 6(4), 463-477.
268. Pyo, J-O.; Nah, J.; Jung, Y-K. Molecules and their functions in autophagy. Exp. Mol. Med., 2012, 44(2), 73-80.
269. Yang, Z.; Klionsky, D. J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol., 2010, 22(2), 124-131.
270. Wullschleger, S.; Loewith, R.; Hall, M. N. TOR signaling in growth and metabolism. Cell, 2006, 124(3), 471-484.
271. Ganley, I. G.; Lam, H.; Wang, J.; Ding, X.; Chen, S.; Jiang, X. ULK1. ATG13. FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem., 2009, 284(18), 12297-12305.
272. Harrison, D. E.; Strong, R.; Sharp, Z. D.; Nelson, J. F.; Astle, C. M.; Flurkey, K.; Nadon, N. L.; Wilkinson, J. E.; Frenkel, K.; Carter, C. S.; Pahor, M.; Javors, M. A.; Fernandez, E.; Miller, R. A. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 2009, 460(7253), 392-395.
273. Kapahi, P.; Zid, B. M.; Harper, T.; Koslover, D.; Sapin, V.; Benzer, S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol., 2004, 14(10), 885-890.
274. Vellai, T.; Takacs-Vellai, K.; Zhang, Y.; Kovacs, A. L.; Orosz, L.; Müller, F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature, 2003, 426(6967), 620.
275. Mattson, M. P. Hormesis defined. Ageing Res. Rev., 2008, 7(1), 1-7.
276. Cuervo, A. M.; Dice, J. F. Age-related decline in chaperone-mediated autophagy. J. Biol. Chem., 2000, 275(40), 31505-31513.
277. Vittorini, S.; Paradiso, C.; Masini, M.; Gori, Z.; Pollera, M.; Bergamini, E. Age-related decline of macroautophagy and liver protein breakdown in the Sprague-Dawley rat: Protective effect of caloric restriction. Aging Clin. Exp. Res., 1995, 7(6), 476-477.
278. Donati, A.; Cavallini, G.; Paradiso, C.; Vittorini, S.; Pollera, M.; Gori, Z.; Bergamini, E. Age-related changes in the au-tophagic proteolysis of rat isolated liver cells: effects of antiaging dietary restrictions. J. Gerontol. A Biol. Sci. Med. Sci., 2001, 56(9), B375-B383.
279. Hansen, M.; Chandra, A.; Mitic, L. L.; Onken, B.; Driscoll, M.; Kenyon, C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet., 2008, 4(2), e24.
280. Simonsen, A.; Cumming, R. C.; Brech, A.; Isakson, P.; Schubert, D. R.; Finley, K. D. Promoting basal levels of au-tophagy in the nervous system enhances longevity and oxi-dant resistance in adult Drosophila. Autophagy, 2008, 4(2), 176-184.
281. Terman, A.; Dalen, H.; Eaton, J. W.; Neuzil, J.; Brunk, U. T. Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp. Gerontol., 2003, 38(8), 863-876.
282. Terman, A.; Brunk, U. T. Aging as a catabolic malfunction. Int. J. Biochem. Cell Biol., 2004, 36(12), 2365-2375.
283. Gonzalez, C. D.; Lee, M-S.; Marchetti, P.; Pietropaolo, M.; Towns, R.; Vaccaro, M. I.; Watada, H.; Wiley, J. W. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy, 2011, 7(1), 2-11.
284. Hara, T.; Nakamura, K.; Matsui, M.; Yamamoto, A.; Naka-hara, Y.; Suzuki-Migishima, R.; Yokoyama, M.; Mishima, K.; Saito, I.; Okano, H.; Mizushima, N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 2006, 441(7095), 885-889.
285. Mathew, R.; Kongara, S.; Beaudoin, B.; Karp, C. M.; Bray, K.; Degenhardt, K.; Chen, G.; Jin, S.; White, E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev., 2007, 21(11), 1367-1381.
286. Filippi-Chiela, E. C.; Villodre, E. S.; Zamin, L. L.; Lenz, G. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One, 2011, 6(6), e20849.
287. Liao, P. C.; Ng, L. T.; Lin, L. T.; Richardson, C. D.; Wang, G-H.; Lin, C-C. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J. Med. Food, 2010, 13(6), 1415-1423.
288. Opipari, A. W., Jr; Tan, L.; Boitano, A. E.; Sorenson, D. R.; Aurora, A.; Liu, J. R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res., 2004, 64(2), 696-703.
289. Puissant, A.; Robert, G.; Fenouille, N.; Luciano, F.; Cas-suto, J. P.; Raynaud, S.; Auberger, P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res., 2010, 70(3), 1042-1052.
290. Ohshiro, K.; Rayala, S. K.; Kondo, S.; Gaur, A.; Vadlamudi, R. K.; El-Naggar, A. K.; Kumar, R. Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer Res., 2007, 67(17), 8164-71.
291. Yamamoto, M.; Suzuki, S. O.; Himeno, M. Resveratrol-induced autophagy in human U373 glioma cells. Oncol. Lett., 2010, 1(3), 489-493.
292. Vingtdeux, V.; Giliberto, L.; Zhao, H.; Chandakkar, P.; Wu, Q.; Simon, J. E.; Janle, E. M.; Lobo, J.; Ferruzzi, M. G.; Da-vies, P.; Marambaud, P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem., 2010, 285(12), 9100-9113.
293. Park, D.; Jeong, H.; Lee, M. N.; Koh, A.; Kwon, O.; Yang, Y. R.; Noh, J.; Suh, P. G.; Park, H.; Ryu, S. H. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci. Rep., 2016, 6, 21772.
294. Scarlatti, F.; Maffei, R.; Beau, I.; Codogno, P.; Ghidoni, R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ., 2008, 15(8), 1318-1329.
295. Puissant, A.; Auberger, P. AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy, 2010, 6(5), 655-657.
296. Wu, Y.; Li, X.; Zhu, J. X.; Xie, W.; Le, W.; Fan, Z.; Jankovic, J.; Pan, T. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinsons disease. Neurosignals, 2011, 19(3), 163-174.
297. Mammucari, C.; Milan, G.; Romanello, V.; Masiero, E.; Rudolf, R.; Del Piccolo, P.; Burden, S. J.; Di Lisi, R.; San-dri, C.; Zhao, J.; Goldberg, A. L.; Schiaffino, S.; Sandri, M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab., 2007, 6(6), 458-471.
298. Morselli, E.; Mariño, G.; Bennetzen, M. V.; Eisenberg, T.; Megalou, E.; Schroeder, S.; Cabrera, S.; Bénit, P.; Rustin, P.; Criollo, A.; Kepp, O.; Galluzzi, L.; Shen, S.; Malik, S. A.; Maiuri, M. C.; Horio, Y.; López-Otín, C.; Andersen, J. S.; Tavernarakis, N.; Madeo, F.; Kroemer, G. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol., 2011, 192(4), 615-629.
299. Armour, S. M.; Baur, J. A.; Hsieh, S. N.; Land-Bracha, A.; Thomas, S. M.; Sinclair, D. A. Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany, N. Y.), 2009, 1(6), 515-528.
300. Xu, X.; Chen, K.; Kobayashi, S.; Timm, D.; Liang, Q. Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy. J. Pharmacol. Exp. Ther., 2012, 341(1), 183-195.
301. Lee, S. B.; Kim, S.; Lee, J.; Park, J.; Lee, G.; Kim, Y.; Kim, J. M.; Chung, J. ATG1, an autophagy regulator, inhibits cell growth by negatively regulating S6 kinase. EMBO Rep., 2007, 8(4), 360-365.
302. McQuary, P. R.; Liao, C. Y.; Chang, J. T.; Kumsta, C.; She, X.; Davis, A.; Chu, C. C.; Gelino, S.; Gomez-Amaro, R. L.; Petrascheck, M.; Brill, L. M.; Ladiges, W. C.; Kennedy, B. K.; Hansen, M. C.elegans S6K Mutants Require a Crea-tine-Kinase-like Effector for Lifespan Extension. Cell Reports, 2016, 14(9), 2059-2067.
303. Ershler, W. B.; Sun, W. H.; Binkley, N.; Gravenstein, S.; Volk, M. J.; Kamoske, G.; Klopp, R. G.; Roecker, E. B.; Daynes, R. A.; Weindruch, R. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res., 1993, 12(4), 225-230.
304. Prasad, S.; Sung, B.; Aggarwal, B. B. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev. Med., 2012, 54(Suppl.), S29-S37.
305. Helenius, M.; Hänninen, M.; Lehtinen, S. K.; Salminen, A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J. Mol. Cell. Cardiol., 1996, 28(3), 487-498.
306. Libermann, T. A.; Baltimore, D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol., 1990, 10(5), 2327-2334.
307. Chandrasekar, B.; Nelson, J. F.; Colston, J. T.; Freeman, G. L. Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol., 2001, 280(5), H2094-H2102.
308. Annabi, B.; Lord-Dufour, S.; Vézina, A.; Béliveau, R. Resveratrol Targeting of Carcinogen-Induced Brain Endo-thelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent. Drug Target Insights, 2012, 6, 1-11.
309. Csiszar, A.; Labinskyy, N.; Podlutsky, A.; Kaminski, P. M.; Wolin, M. S.; Zhang, C.; Mukhopadhyay, P.; Pacher, P.; Hu, F.; de Cabo, R.; Ballabh, P.; Ungvari, Z. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol., 2008, 294(6), H2721-H2735.
310. Lu, X.; Ma, L.; Ruan, L.; Kong, Y.; Mou, H.; Zhang, Z.; Wang, Z.; Wang, J. M.; Le, Y. Resveratrol differentially modulates inflammatory responses of microglia and astro-cytes. J. Neuroinflammation, 2010, 7, 46.
311. Manna, S. K.; Mukhopadhyay, A.; Aggarwal, B. B. Resvera-trol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid pe-roxidation. J. Immunol., 2000, 164(12), 6509-6519.
312. Shakibaei, M.; Csaki, C.; Nebrich, S.; Mobasheri, A. Resveratrol suppresses interleukin-1ß-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol., 2008, 76(11), 1426-1439.
313. Kundu, J. K.; Shin, Y. K.; Kim, S. H.; Surh, Y. J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis, 2006, 27(7), 1465-1474.
314. Zhong, L. M.; Zong, Y.; Sun, L.; Guo, J. Z.; Zhang, W.; He, Y.; Song, R.; Wang, W-M.; Xiao, C-J.; Lu, D. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS One, 2012, 7(2), e32195.
315. Zenz, R.; Eferl, R.; Scheinecker, C.; Redlich, K.; Smolen, J.; Schonthaler, H. B.; Kenner, L.; Tschachler, E.; Wagner, E. F. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res. Ther., 2008, 10(1), 201.
316. Castello, L.; Froio, T.; Cavallini, G.; Biasi, F.; Sapino, A.; Leonarduzzi, G.; Bergamini, E.; Poli, G.; Chiarpotto, E. Calorie restriction protects against age-related rat aorta sclerosis. FASEB J., 2005, 19(13), 1863-1865.
317. Kim, M. H.; Yoo, D. S.; Lee, S. Y.; Byeon, S. E.; Lee, Y. G.; Min, T.; Rho, H. S.; Rhee, M. H.; Lee, J.; Cho, J. Y. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Pharmazie, 2011, 66(4), 293-300.
318. Palsamy, P.; Subramanian, S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol., 2010, 224(2), 423-432.
319. Sánchez-Fidalgo, S.; Cárdeno, A.; Villegas, I.; Talero, E.; de la Lastra, C. A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol., 2010, 633(1-3), 78-84.
320. Zhang, F.; Shi, J. S.; Zhou, H.; Wilson, B.; Hong, J. S.; Gao, H-M. Resveratrol protects dopamine neurons against lipo-polysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol. Pharmacol., 2010, 78(3), 466-477.
321. Yeung, F.; Hoberg, J. E.; Ramsey, C. S.; Keller, M. D.; Jones, D. R.; Frye, R. A.; Mayo, M. W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J., 2004, 23(12), 2369-2380.
322. Tabata, Y.; Takano, K.; Ito, T.; Iinuma, M.; Yoshimoto, T.; Miura, H.; Kitao, Y.; Ogawa, S.; Hori, O. Vaticanol B, a resveratrol tetramer, regulates endoplasmic reticulum stress and inflammation. Am. J. Physiol. Cell Physiol., 2007, 293(1), C411-C418.
323. Peng, W.; Ma, Y. Y.; Zhang, K.; Zhou, A. Y.; Zhang, Y.; Wang, H.; Du, Z.; Zhao, D. G. Synthesis and Biological Evaluation of Novel Resveratrol-NSAID Derivatives as Anti-inflammatory Agents. Chem. Pharm. Bull. (Tokyo), 2016, 64(6), 609-615.
324. Lei, M.; Wang, J. G.; Xiao, D. M.; Fan, M.; Wang, D. P.; Xiong, J. Y.; Chen, Y.; Ding, Y.; Liu, S. L. Resveratrol inhibits interleukin 1ß-mediated inducible nitric oxide syn-thase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-βB activity. Eur. J. Pharmacol., 2012, 674(2-3), 73-79.
325. Itoh, K.; Wakabayashi, N.; Katoh, Y.; Ishii, T.; Igarashi, K.; Engel, J. D.; Yamamoto, M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev., 1999, 13(1), 76-86.
326. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol., 1956, 11(3), 298-300.
327. Harman, D. Free radical theory of aging: dietary implications. Am. J. Clin. Nutr., 1972, 25(8), 839-843.
328. Harman, D. Free radical theory of aging. Mutat. Res., 1992, 275(3-6), 257-266.
329. Tullet, J. M.; Hertweck, M.; An, J. H.; Baker, J.; Hwang, J. Y.; Liu, S.; Oliveira, R. P.; Baumeister, R.; Blackwell, T. K. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell, 2008, 132(6), 1025-1038.
330. Chen, C. Y.; Jang, J. H.; Li, M. H.; Surh, Y. J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun., 2005, 331(4), 993-1000.
331. Kutuk, O.; Poli, G.; Basaga, H. Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling. Toxicol. Sci., 2006, 90(1), 120-132.
332. Rubiolo, J. A.; Mithieux, G.; Vega, F. V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol., 2008, 591(1-3), 66-72.
333. Ungvari, Z.; Bagi, Z.; Feher, A.; Recchia, F. A.; Sonntag, W. E.; Pearson, K.; de Cabo, R.; Csiszar, A. Resveratrol confers endothelial protection via activation of the antioxi-dant transcription factor Nrf2. Am. J. Physiol. Heart Circ. Physiol., 2010, 299(1), H18-H24.
334. Liu, Y.; Chan, F.; Sun, H.; Yan, J.; Fan, D.; Zhao, D.; An, J.; Zhou, D. Resveratrol protects human keratinocytes Ha-CaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression. Eur. J. Pharmacol., 2011, 650(1), 130-137.
335. Csiszar, A.; Sosnowska, D.; Wang, M.; Lakatta, E. G.; Sonntag, W. E.; Ungvari, Z. Age-associated proinflammato-ry secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment. J. Gerontol. A Biol. Sci. Med. Sci., 2012, 67(8), 811-820.
336. Ghanim, H.; Sia, C. L.; Korzeniewski, K.; Lohano, T.; Abu-aysheh, S.; Marumganti, A.; Chaudhuri, A.; Dandona, P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab., 2011, 96(5), 1409-1414.
337. Wagner, A. E.; Boesch-Saadatmandi, C.; Breckwoldt, D.; Schrader, C.; Schmelzer, C.; Döring, F.; Hashida, K.; Hori, O.; Matsugo, S.; Rimbach, G. Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2. BMC Complement. Altern. Med., 2011, 11, 1.
338. Putics, A.; Végh, E. M.; Csermely, P.; Soti, C. Resveratrol induces the heat-shock response and protects human cells from severe heat stress. Antioxid. Redox Signal., 2008, 10(1), 65-75.
339. Tatar, M.; Khazaeli, A. A.; Curtsinger, J. W. Chaperoning extended life. Nature, 1997, 390(6655), 30.
340. Barger, J. L.; Kayo, T.; Pugh, T. D.; Prolla, T. A.; Weindruch, R. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp. Gerontol., 2008, 43(9), 859-866.
341. Terzibasi, E.; Lefrançois, C.; Domenici, P.; Hartmann, N.; Graf, M.; Cellerino, A. Effects of dietary restriction on mortality and age-related phenotypes in the short-lived fish Nothobranchius furzeri. Aging Cell, 2009, 8(2), 88-99.
342. Kim, S. J.; Lee, Y. H.; Han, M. D.; Mar, W.; Kim, W. K.; Nam, K. W. Resveratrol, purified from the stem of Vitis coignetiae Pulliat, inhibits food intake in C57BL/6J Mice. Arch. Pharm. Res., 2010, 33(5), 775-780.
343. Antosh, M.; Fox, D.; Helfand, S. L.; Cooper, L. N.; Neretti, N. New comparative genomics approach reveals a conserved health span signature across species. Aging (Albany, N. Y.), 2011, 3(6), 576-583.
344. Raitakari, M.; Ilvonen, T.; Ahotupa, M.; Lehtimäki, T.; Harmoinen, A.; Suominen, P.; Elo, J.; Hartiala, J.; Rai-takari, O. T. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler. Thromb. Vasc. Biol., 2004, 24(1), 124-128.
345. Pallauf, K.; Bendall, J. K.; Scheiermann, C.; Watschinger, K.; Hoffmann, J.; Roeder, T.; Rimbach, G. Vitamin C and lifespan in model organisms. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association, 2013, 58, 255-263.
346. Ernst, I. M.; Pallauf, K.; Bendall, J. K.; Paulsen, L.; Nikolai, S.; Huebbe, P.; Roeder, T.; Rimbach, G. Vitamin E supplementation and lifespan in model organisms. Ageing Res. Rev., 2013, 12(1), 365-375.
347. Nakagawa, S.; Lagisz, M.; Hector, K. L.; Spencer, H. G. Comparative and meta-analytic insights into life extension via dietary restriction. Aging Cell, 2012, 11(3), 401-409.
348. Nikolai, S.; Pallauf, K.; Huebbe, P.; Rimbach, G. Energy restriction and potential energy restriction mimetics. Nutr. Res. Rev., 2015, 28(2), 100-120.
349. Pallauf, K.; Rimbach, G. Autophagy, polyphenols and healthy ageing. Ageing Res. Rev., 2013, 12(1), 237-252.
350. Howells, L. M.; Berry, D. P.; Elliott, P. J.; Jacobson, E. W.; Hoffmann, E.; Hegarty, B.; Brown, K.; Steward, W. P.; Gescher, A. J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastasessafety, pharmacokinetics, and pharmacodynam-ics. Cancer Prev. Res. (Phila.), 2011, 4(9), 1419-1425.